|
WHICAP GWAS |
|
|
635884 |
|
WashU2 GWAS |
|
|
540469 |
|
WashU1 GWAS |
|
|
543614 |
|
University of Pittsburgh GWAS |
|
|
1040526 |
|
UAB/HudsonAlpha Families with Neurodegenerative Diseases |
|
|
|
|
UAB ADRC Genetic Data (via DSS) |
|
|
|
|
Transethnic GWAS Summary Statistics - Jun et al. (2017) |
|
|
|
|
The Prediction of Alzheimer’s Disease through Multi-Trait Genetic Modeling (via DSS) |
|
|
|
|
TGEN II GWAS |
|
|
759916 |
|
TARCC GWAS |
|
|
648974 |
|
Summary Statistics of IGAP Age at onset survival GWAS dataset - Huang KL et al. (2017) |
|
|
|
|
SORL1 coding variants and risk for AD |
|
|
89 |
|
SORL1 coding variants and risk for AD |
|
|
89 |
|
Singapore Longitudinal study of Vascular Cognitive Impairment and Dementia |
|
|
|
|
Similar Genetic Architecture of Alzheimer’s Disease and Differential APOE Effect Between Sexes- Wang et al. 2021 |
|
|
|
|
Sex-specific genetic predictors of Alzheimer’s disease biomarkers – Deming et al., 2018 (via DSS) |
|
|
|
|
Sex-specific genetic architecture of late-life memory performance (via DSS) |
|
|
|
|
Sex differences in the genetic predictors of Alzheimer’s pathology – Dumitrescu et al., 2019 (via DSS) |
|
|
|
|
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease – Eissman et al., 2022 (via DSS) |
|
|
|
|
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation(JOTROL TM) (via DSS) |
|
|
|
